Ivan Gordeev
Overview
Explore the profile of Ivan Gordeev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1770
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pfeffer M, Claggett B, Assmann S, Boineau R, Anand I, Clausell N, et al.
Circulation
. 2014 Nov;
131(1):34-42.
PMID: 25406305
Background: Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) patients with heart failure and preserved left ventricular ejection fraction assigned to spironolactone did not achieve a...
12.
Pitt B, Pfeffer M, Assmann S, Boineau R, Anand I, Claggett B, et al.
N Engl J Med
. 2014 Apr;
370(15):1383-92.
PMID: 24716680
Background: Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction. We evaluated the effects of spironolactone in patients with heart failure and...
13.
Shah S, Heitner J, Sweitzer N, Anand I, Kim H, Harty B, et al.
Circ Heart Fail
. 2012 Dec;
6(2):184-92.
PMID: 23258572
Background: Treatment of Preserved Cardiac Function with an Aldosterone Antagonist (TOPCAT) is an ongoing randomized controlled trial of spironolactone versus placebo for heart failure with preserved ejection fraction (HFpEF). We...
14.
Desai A, Lewis E, Li R, Solomon S, Assmann S, Boineau R, et al.
Am Heart J
. 2011 Dec;
162(6):966-972.e10.
PMID: 22137068
Background: Despite increasing prevalence of heart failure (HF) in patients with preserved ejection fraction (PEF), there are no available therapies proven to reduce morbidity and mortality. Aldosterone, a potent stimulator...